Neurocrine Biosciences, Inc. Common Stock NBIX
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-12T19:51:57.275Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T19:51:52.030869989Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T19:51:56.725032+00:00
Neurocrine Biosciences, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 185.95 | 65.1% | 10.2% | 159.51 | 56.1% | 7.4% |
| 25Δ | 178.06 | 39.8% | 5.3% | 165.26 | 32.2% | 3.7% |
| 30Δ | 175.92 | 36.8% | 4.2% | 166.39 | 31.1% | 3.3% |
| 35Δ | 174.33 | 36.3% | 3.6% | 167.51 | 30.0% | 2.8% |
| 40Δ | 173.15 | 37.8% | 3.3% | 168.64 | 28.9% | 2.3% |
| 45Δ | 171.96 | 39.2% | 2.9% | 169.77 | 27.8% | 1.8% |
| 50Δ | 170.78 | 40.6% | 2.6% | 170.70 | 27.3% | 1.5% |
| 55Δ | 169.53 | 41.6% | 2.3% | 171.59 | 27.0% | 1.3% |
| 60Δ | 168.12 | 41.9% | 2.0% | 172.48 | 26.8% | 1.1% |
| 65Δ | 166.72 | 42.2% | 1.6% | 173.37 | 26.5% | 0.9% |
| 70Δ | 165.31 | 42.5% | 1.3% | 174.25 | 26.3% | 0.7% |
| 75Δ | 163.41 | 43.7% | 1.1% | |||
| 80Δ | 161.37 | 45.1% | 0.9% | |||
20Δ
- Pseudo strike
- 185.95
- IV
- 65.1%
- B/E move
- 10.2%
- Pseudo strike
- 159.51
- IV
- 56.1%
- B/E move
- 7.4%
25Δ
- Pseudo strike
- 178.06
- IV
- 39.8%
- B/E move
- 5.3%
- Pseudo strike
- 165.26
- IV
- 32.2%
- B/E move
- 3.7%
30Δ
- Pseudo strike
- 175.92
- IV
- 36.8%
- B/E move
- 4.2%
- Pseudo strike
- 166.39
- IV
- 31.1%
- B/E move
- 3.3%
35Δ
- Pseudo strike
- 174.33
- IV
- 36.3%
- B/E move
- 3.6%
- Pseudo strike
- 167.51
- IV
- 30.0%
- B/E move
- 2.8%
40Δ
- Pseudo strike
- 173.15
- IV
- 37.8%
- B/E move
- 3.3%
- Pseudo strike
- 168.64
- IV
- 28.9%
- B/E move
- 2.3%
45Δ
- Pseudo strike
- 171.96
- IV
- 39.2%
- B/E move
- 2.9%
- Pseudo strike
- 169.77
- IV
- 27.8%
- B/E move
- 1.8%
50Δ
- Pseudo strike
- 170.78
- IV
- 40.6%
- B/E move
- 2.6%
- Pseudo strike
- 170.70
- IV
- 27.3%
- B/E move
- 1.5%
55Δ
- Pseudo strike
- 169.53
- IV
- 41.6%
- B/E move
- 2.3%
- Pseudo strike
- 171.59
- IV
- 27.0%
- B/E move
- 1.3%
60Δ
- Pseudo strike
- 168.12
- IV
- 41.9%
- B/E move
- 2.0%
- Pseudo strike
- 172.48
- IV
- 26.8%
- B/E move
- 1.1%
65Δ
- Pseudo strike
- 166.72
- IV
- 42.2%
- B/E move
- 1.6%
- Pseudo strike
- 173.37
- IV
- 26.5%
- B/E move
- 0.9%
70Δ
- Pseudo strike
- 165.31
- IV
- 42.5%
- B/E move
- 1.3%
- Pseudo strike
- 174.25
- IV
- 26.3%
- B/E move
- 0.7%
75Δ
- Pseudo strike
- 163.41
- IV
- 43.7%
- B/E move
- 1.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 161.37
- IV
- 45.1%
- B/E move
- 0.9%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 39.34% | |
| 39.50% | |
| 40.34% | |
| 40.64% | |
| 40.06% | |
| 40.18% | |
| 40.09% | |
| 39.94% | |
| 40.15% | |
| 41.90% |
Drug Manufacturers - Specialty & Generic
OGI
Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
More →PAHC
Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The…
More →PBH
Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The…
More →PCRX
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is…
More →PRGO
Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
More →RDY
Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
More →